Your browser doesn't support javascript.
loading
Antibiotics Prophylaxis for Operative Hysteroscopy.
Muzii, Ludovico; Di Donato, Violante; Boni, Terenzio; Gaglione, Raffaele; Marana, Riccardo; Mazzon, Ivan; Imperiale, Ludovica; De Medici, Caterina; Ruggiero, Alfonso; Panici, Pierluigi Benedetti.
Afiliação
  • Muzii L; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
  • Di Donato V; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
  • Boni T; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
  • Gaglione R; 2 Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.
  • Marana R; 2 Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.
  • Mazzon I; 3 Arbor Vitae Center for Endoscopic Gynecology, Clinica Nuova Villa Claudia, Rome, Italy.
  • Imperiale L; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
  • De Medici C; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
  • Ruggiero A; 4 Department of Obstetrics and Gynecology, University of Rome Campus Bio-Medico, Rome, Italy.
  • Panici PB; 1 Department of Gynecology, Obstetrics, and Urology, Umberto I, Sapienza University of Rome, Rome, Italy.
Reprod Sci ; 24(4): 534-538, 2017 04.
Article em En | MEDLINE | ID: mdl-27470152
ABSTRACT

OBJECTIVE:

To evaluate the incidence of infectious complications and effect of prophylactic antibiotic administration during operative hysteroscopic procedures.

METHODS:

A multicentric randomized controlled trial was conducted between January 2012 and December 2013. Women (n = 180) affected by endometrial hyperplasia, myomas, or endometrial polyps undergoing operative hysteroscopy were randomized to receive cefazolin 2 g intravenously 30 minutes prior to the procedure (n = 91) and no treatment (n = 89).

RESULTS:

No statistical difference in terms of postoperative fever (2.4% vs 2.3%, P = .99), endometritis (0% vs 0%), pain (6.0% vs 10.4%, P = .40), cervicitis-vaginitis (0% vs 0%), pelvic abscess (0% vs 0%), pelvic inflammatory disease (0% vs 0%), and bleeding (0% vs 0%) was noticed. No statistical difference in terms of side effects attributable to antibiotic prophylaxis such as allergy (0% vs 4.8%, P = .12), nausea (10.7% vs 17.4%, P = .27), vomiting (3.6% vs 4.6%, P = .99), diarrhea (4.8% vs 5.4%, P = .99), cephalea (9.5% vs 3.5%, P = .13), dizziness (4.8% vs 2.3%, P = .44), and meteorism (5.4% vs 3.4%, P = .99) was noticed.

CONCLUSION:

The results of the current study support the recommendation not to prescribe routine antibiotic prophylaxis prior to operative hysteroscopy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Pólipos / Neoplasias Uterinas / Histeroscopia / Antibioticoprofilaxia / Hiperplasia Endometrial / Leiomioma Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Reprod Sci Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Pólipos / Neoplasias Uterinas / Histeroscopia / Antibioticoprofilaxia / Hiperplasia Endometrial / Leiomioma Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Reprod Sci Ano de publicação: 2017 Tipo de documento: Article